brain metastasis

Peter Fecci, MD, PhD, is the co-editor of the new e-book — "It Takes a Village: The Expanding Multi-Disciplinary Approach to Brain Metastasis."

A research team led by Ann Marie Pendergast, PhD, found, in animal studies, that a leukemia drug disrupted HER2-positive breast cancer-spread to the brain.

A decade since the first drug, an immunotherapy, was approved to treat metastatic melanoma, a leading clinician researcher goes head to head with melanoma brain metastasis.

Sponsored by Duke Neurosurgery, the Duke Center for Brain & Spine Metastasis launches its inaugural national colloquium June 25 & 26.

Renowned DCI neurosurgeon-scientist Peter Fecci, MD, PhD, is one of three SoM faculty members to be inducted this year into ASCI.

Duke Cancer Institute has given stage 4 cancer survivor Milos Bogetic precious extra time with his wife and growing young son.

This holiday season, two stage 4 lung cancer survivors share their inspirational stories of healing and how they are passing on the gift.

A Duke research team has identified a molecular process by which lung cancer cells metastasize to the brain.

One top trainee from each of the eight DCI Research Programs presented their pioneering cancer research projects. Benjamin Mayro received the Bell Award.

Co-director of the Stanford Stereotactic Radiosurgery Program Scott Soltys, MD, presents on the evolution of stereotactic radiosurgery for brain metastases.

Cancer doesn't wait for COVID-19.

A world-class team has come together to provide new answers for people with cancer that has spread to the brain and the spine.

Carey Anders, MD, who completed a residency and fellowship at Duke, rounds out the leadership team at the Duke Center for Brain and Spine Metastasis

Non-profit director and mother Elizabeth Levene fights cancer that has spread to the brain.

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

Used to rescuing others in medical distress, Jerry Sams never expected to be the one in need of saving.

"It's my comfort spot. I can live my life when I’m here, even if I’m not feeling well, and they are always here to take care of me.”

This year's Annual Report spotlights the work of the new Duke Center for Brain and Spine Metastasis at DCI as well as a Duke-Durham stomach cancer prevention partnership. 

In a new Cell Reports paper, DCI researchers report they've uncovered actionable targets for the treatment of brain metastases harboring lung adenocarcinoma.

April Salama, MD, director of the Melanoma Disease Group, has joined the Duke Center for Brain and Spine Metastasis at DCI as associate medical director.

Duke Cancer Institute hosted its Sixth Annual Scientific Retreat on Friday, October 25; attracting 166 DCI physicians, researchers, staff, and guests.

As recently as ten years ago, patients with brain metastasis were rarely offered surgical treatment.It was essentially viewed as a death sentence.